Find Reports
Select Report Type
Reimbursement Review
Displaying 1201 - 1225 of 1258
Please scroll or swipe to the right to view the full content.
| Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|
| N/A | nivolumab | Hodgkin lymphoma | Active | PX0376-000 | ||||
| N/A | fidaxomicin | Clostridium difficile infection | Active | SX0754-000 | ||||
| N/A | Dabrafenib trametinib | Head and neck cancer | Active | PX0373-000 | ||||
| N/A | regorafenib | Metastatic osteosarcoma | Active | PX0374-000 | ||||
| Ferinject | ferric carboxymaltose | Iron deficiency in adult patients with heart failure | Active | SR0852-000 | ||||
| TBC | omaveloxolone | Friedreich’s ataxia | Active | SR0864-000 | ||||
| N/A | cabozantinib | Neuroendocrine tumours | Active | PX0378-000 | ||||
| N/A | pertuzumab | HER2+ breast cancer | Active | PX0379-000 | ||||
| N/A | trabectedin | Soft tissue and uterine leiomyosarcoma | Active | PX0377-000 | ||||
| Hepcludex | bulevirtide | chronic hepatitis delta virus (HDV) infection | Pending | SR0881-000 | ||||
| Omvoh | mirikizumab | Crohn’s disease | Pending | SR0880-000 | ||||
| Bylvay | odevixibat | Alagille syndrome | Pending | SR0884-000 | ||||
| Xarelto | Rivaroxaban | Deep-vein thrombosis without symptomatic pulmonary embolism | Complete | SF0295-000 | ||||
| Myrbetriq | Mirabegron | Overactive bladder | Withdrawn | SR0319-000 | ||||
| Invokana | Canagliflozin | Diabetes Mellitus, Type 2 | Withdrawn | SR0335-000 | ||||
| Komboglyze | Saxagliptin + metformin | Diabetes Mellitus, Type 2 | Withdrawn | SR0336-000 | ||||
| Lemtrada | Alemtuzumab | Multiple sclerosis, relapsing-remitting | Withdrawn | SR0355-000 | ||||
| Humira | Adalimumab | ulcerative colitis | Withdrawn | SR0365-000 | ||||
| Treanda (in combination with rituximab) | Bendamustine hydrochloride | Chronic Lymphocytic Leukemia | Withdrawn | PC0040-000 | ||||
| Adcetris | Brentuximab vedotin | Withdrawn | PC0086-000 | |||||
| Cyramza | Ramucirumab | Cancelled | PC0078-000 | |||||
| Mifegymiso | Mifepristone and misoprostol | Medical termination of pregnancy (gestational age up to 49 days) | Withdrawn | SR0473 -000 | ||||
| Praxbind | Idarucizumab (Drug Plan Submission) | Reversal of dabigatran anticoagulant effects | Withdrawn | SR0492-000 | ||||
| Venclexta | Venetoclax | Withdrawn | PC0087-000 | |||||
| VFEND | Voriconazole | Aspergillosis, Invasive | Withdrawn | SR0020-000 |
Health Technology Review
Displaying 576 - 589 of 589
Horizon Scan
Displaying 101 - 111 of 111
Projects in Progress
Displaying 26 - 40 of 40
View All Reports
Displaying 1201 - 1225 of 2093
Please scroll or swipe to the right to view the full content.